Response to COVID-19 webinar series part V: Navigating clinical trials during the COVID-19 pandemic

Randy Prebula served as a panelist and Heidi Forster Gertner as moderator for part five of Global Health Care's "Response to COVID-19" webinar series on 14 May.

How landmark OTC drug reform legislation will affect your business

A team of our lawyers who counsel on Over-the-Counter (OTC) drug regulation will discuss the long-awaited OTC drug monograph reform that was part of the Coronavirus Aid, Relief, and...

How COVID-19 is changing the clinical trials landscape

Among the numerous repercussions of the COVID-19 pandemic, life sciences companies and academic medical centers are now faced with significant disruptions and threats to their clinical...

Loading data